Boston Scientific disclosed that a cyberattack disrupted its global IT systems and affected its ability to process and ship customer orders, without providing a timeline for full restoration. The company said it is still investigating the incident’s scope and impacts as part of an ongoing series of cyber events across med-tech this year. The disclosure matters operationally for device companies because order-processing interruptions can translate into delays in treatment availability and downstream regulatory obligations tied to distribution and documentation. It also highlights how “connected” enterprise systems have become a key vulnerability across medical supply chains. Boston Scientific joins a list of med-tech firms reporting major cyber incidents, reinforcing that cybersecurity has become a board-level priority for healthcare technology operators.